Red Light Treatment in an Axotomy Model of Neurodegeneration

doi:10.1111/php.12606

Paper

Red Light Treatment in an Axotomy Model of Neurodegeneration

Published Jul 1, 2016 · Kathy Beirne, M. Różanowska, M. Votruba

Photochemistry and Photobiology

Q2 SJR score

10

Citations

0

Influential Citations

Open Access PDF Full text Semantic Scholar

Abstract

Red light has been shown to provide neuroprotective effects. Axotomizing the optic nerve initiates retinal ganglion cell (RGC) degeneration, and an early marker of this is dendritic pruning. We hypothesized that 670 nm light can delay axotomy‐induced dendritic pruning in the retinal explant. To test this hypothesis, we monitored the effects of 670 nm light (radiant exposure of 31.7 J cm−2), on RGC dendritic pruning in retinal explants from C57BL/6J mice, at 40 min, 8 h and 16 h post axotomy. For sham‐treated retinae, area under the Sholl curve, peak of the Sholl curve and dendritic length at 8 h post axotomy showed statistically significant reductions by 42.3% (P = 0.008), 29.8% (P = 0.007) and 38.4% (P = 0.038), respectively, which were further reduced after 16 h by 40.56% (P < 0.008), 33.9% (P < 0.007), 45.43% (P < 0.006), respectively. Dendritic field area was also significantly reduced after 16 h, by 44.23% (P < 0.019). Such statistically significant reductions were not seen in light‐treated RGCs at 8 or 16 h post axotomy. The results demonstrate the ability of 670 nm light to partially prevent ex vivo dendropathy in the mouse retina, suggesting that it is worth exploring as a treatment option for dendropathy‐associated neurodegenerative diseases, including glaucoma and Alzheimer's disease.

Non-RCT

Animal Study

Study Snapshot

670 nm red light can partially prevent retinal ganglion cell degeneration in mice, suggesting potential as a treatment option for dendropathy-associated neurodegenerative diseases like glaucoma and Alzheimer's disease.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Red Light Treatment in an Axotomy Model of Neurodegeneration

Sign up to use Study Snapshot

References

Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients.

Low level laser therapy (LLLT) effectively reduces oral mucositis in head and neck cancer patients, but its potential to enhance tumor behaviors requires further investigation.

Synapse Loss and Dendrite Remodeling in a Mouse Model of Glaucoma

Dendritic remodeling and synapse pruning occur near-simultaneously in retinal ganglion cells in glaucoma, potentially causing early dysfunction in the eye.

Photobiomodulation with 660-nm and 780-nm laser on activated J774 macrophage-like cells: Effect on M1 inflammatory markers.

Photobiomodulation with 660-nm and 780-nm lasers reduces M1 inflammatory markers, while 660-nm lasers up-regulate IL-6 expression and production, suggesting a time-dependent modulation of macrophages in tissue repair.

Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson’s Disease

Photobiomodulation (PBM) treatment effectively reduces dopaminergic neuronal loss and motor impairment in a rat model of Parkinson's disease, suggesting potential therapeutic applications for related synucleinopathies.

Mitochondrial decline precedes phenotype development in the complement factor H mouse model of retinal degeneration but can be corrected by near infrared light

Near infrared light can correct mitochondrial decline in mice models of age-related macular degeneration, potentially reducing inflammation and photoreceptor loss.

Citations

The potential for mitochondrial therapeutics in the treatment of primary open-angle glaucoma: a review

Mitochondrial therapeutics show potential in slowing the progression of primary open-angle glaucoma by protecting against mitochondrial decline and targeting neuronal damage and symptom manifestations.

Considerations for the Use of Photobiomodulation in the Treatment of Retinal Diseases

Photobiomodulation (PBM) shows potential in treating retinal diseases, but the effectiveness of PBM varies greatly based on the light source and illumination parameters used in studies.

Electrical, Electromagnetic, Ultrasound Wave Therapies, and Electronic Implants for Neuronal Rejuvenation, Neuroprotection, Axonal Regeneration, and IOP Reduction.

Electrical, electromagnetic, and ultrasound wave therapies show potential in promoting neuronal regeneration and functional recovery in various disorders of the central nervous system, peripheral nervous system, retina, and optic nerve.

Light-emitting diode phototherapy: pain relief and underlying mechanisms

LED phototherapy offers low-cost, safe, and effective pain relief for various conditions, with potential underlying mechanisms including physicochemical and neurobiological mechanisms.

Red Light Irradiation In Vivo Upregulates DJ-1 in the Retinal Ganglion Cell Layer and Protects against Axotomy-Related Dendritic Pruning

Red light irradiation can protect retinal ganglion cells from degeneration and oxidative stress, supporting its potential as a treatment for diseases involving RGC degeneration.